Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05975593 · ClinicalTrials.gov registry record · NA
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
A NA study of Pancreatic Cancer and Cervical Cancer, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05975593 is a NA study of Pancreatic Cancer and Cervical Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 60 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05975593, a NA study of Pancreatic Cancer and Cervical Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment-related data (imaging, dosimetry, clinical) before, during, and after treatment with definitive-intent chemoradiotherapy for patients with locally advanced cervical and pancreatic cancer.
Conditions Studied
Interventions
- OTHER Blood collection
- OTHER Tumor collection via biopsy
- DEVICE Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-01-11 |
| Est. Completion | 2032-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05975593
The ClinicalTrials.gov registry entry for NCT05975593 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Blood collection is the first listed.
NCT05975593 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05975593 about?
NCT05975593 is a clinical study titled "MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial". This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment-related data (imaging, dosimetry, clinical) before, during, and after treatment with definitive-intent chemoradiotherapy for patients with locally ...
What is the current status of trial NCT05975593?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-01-11. Estimated completion is 2032-12-31.
What conditions does trial NCT05975593 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Cervical Cancer, Pancreas Cancer, Cancer of the Pancreas, Locally Advanced Pancreatic Carcinoma.
What interventions are being tested in trial NCT05975593?
The interventions under investigation include: Blood collection (OTHER), Tumor collection via biopsy (OTHER), Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI) (DEVICE).
Who is sponsoring clinical trial NCT05975593?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05975593 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.